Guidance

Live attenuated influenza vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated influenza vaccine (Fluenz Trivalent®) in accordance with the national seasonal influenza vaccination programme.

Applies to England

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

°Õ³ó¾±²õÌýPGDÌýtemplate supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent®) as part of theÌýnational seasonal influenza vaccination programme.

LAIVÌýPGDÌýversion 14.00 is valid from 1 September 2024 to 1 April 2025.

Practitioners must not use thisÌýPGDÌýtemplate until it has been authorised in Section 2. This is a legal requirement (seeÌý).

°Õ³ó¾±²õÌýPGDÌýtemplate should be used with reference to current national guidance, theÌýGreen Book, andÌýÌýfor the vaccine.

Updates to this page

Published 10 July 2024

Sign up for emails or print this page